久久婷婷国产综合精品,久久久久久久性潮,换脸国产av一区二区三区,韩国精品一区二区三区无码视频 ,久久久久成人精品无码

  • AbbVie receives EC grant to market HCV treatment Maviret pharmaceutical-technology
    August 02, 2017
    The European Commission (EC) has granted marketing authorisation for AbbVie’s Maviret (glecaprevir / pibrentasvir) to treat adult patients with chronic hepatitis C virus (HCV) infection across all major genotypes (GT1-6).

Contact Us

PharmaSources@imsinoexpo.com

Tel: (+86) 400 610 1188

WhatsApp/Telegram/Wechat: +86 13621645194
+86 15021993094

PharmaSources Customer Service